• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiovascular complications in COVID-19: A systematic review and meta-analysis.

作者信息

Kunutsor Setor K, Laukkanen Jari A

机构信息

National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK; Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Learning & Research Building (Level 1), Southmead Hospital, Bristol, UK.

Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland; Institute of Clinical Medicine, Department of Medicine, University of Eastern Finland, Kuopio, Finland; Central Finland Health Care District Hospital District, Department of Medicine, Jyväskylä, Finland District, Jyväskylä, Finland.

出版信息

J Infect. 2020 Aug;81(2):e139-e141. doi: 10.1016/j.jinf.2020.05.068. Epub 2020 Jun 3.

DOI:10.1016/j.jinf.2020.05.068
PMID:32504747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7832225/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e351/7832225/a52554e6116e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e351/7832225/a52554e6116e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e351/7832225/a52554e6116e/gr1_lrg.jpg

相似文献

1
Cardiovascular complications in COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎的心血管并发症：一项系统评价与荟萃分析
J Infect. 2020 Aug;81(2):e139-e141. doi: 10.1016/j.jinf.2020.05.068. Epub 2020 Jun 3.
2
Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis.2019年冠状病毒病（COVID-19）与心血管风险：一项荟萃分析。
Prog Cardiovasc Dis. 2020 Jul-Aug;63(4):527-528. doi: 10.1016/j.pcad.2020.05.001. Epub 2020 May 7.
3
Call to action for the cardiovascular side of COVID-19.针对新冠病毒病心血管方面的行动呼吁。
Eur Heart J. 2020 May 14;41(19):1796-1797. doi: 10.1093/eurheartj/ehaa301.
4
Towards precision management of cardiovascular patients with COVID-19 to reduce mortality.实现对新冠肺炎心血管疾病患者的精准管理以降低死亡率。
Prog Cardiovasc Dis. 2020 Jul-Aug;63(4):529-530. doi: 10.1016/j.pcad.2020.04.012. Epub 2020 Apr 28.
5
Guidance for Health Care Providers on Management of Cardiovascular Complications in Patients Suspected or Confirmed with COVID 19 Virus Infection.针对疑似或确诊感染新冠病毒患者心血管并发症管理的医疗服务提供者指南。
J Assoc Physicians India. 2020 May;68(5):46-49.
6
CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic.CAPACITY-COVID：一项欧洲登记研究，旨在确定心血管疾病在新冠疫情中的作用。
Eur Heart J. 2020 May 14;41(19):1795-1796. doi: 10.1093/eurheartj/ehaa280.
7
An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases.一种急性呼吸道感染遭遇了最常见的非传染性流行病——新冠肺炎与心血管疾病。
JAMA Cardiol. 2020 Jul 1;5(7):743-744. doi: 10.1001/jamacardio.2020.0934.
8
COVID-19 Fatigue: Not So Fast.新冠疲劳：没那么快。
JACC Heart Fail. 2020 Jul;8(7):592-594. doi: 10.1016/j.jchf.2020.06.001. Epub 2020 Jun 4.
9
Fear of Coronavirus Disease 2019-An Emerging Cardiac Risk.对2019冠状病毒病的恐惧——一种新出现的心脏风险。
JAMA Cardiol. 2020 Sep 1;5(9):981-982. doi: 10.1001/jamacardio.2020.2890.
10
Coronavirus and the Heart | A Case Report on the Evolution of COVID-19 Associated with Cardiological Evolution.冠状病毒与心脏 | 一例关于 COVID-19 演变与心脏病变相关的病例报告
Arq Bras Cardiol. 2020 May 11;114(5):839-842. doi: 10.36660/abc.20200263.

引用本文的文献

1
Prognostic Value of Fragmented QRS on Admission Electrocardiogram among Patients Hospitalized with COVID-19: A Single-Center Report, Systematic Review, and Meta-Analysis.COVID-19住院患者入院心电图碎裂QRS波的预后价值：单中心报告、系统评价和荟萃分析
Acta Cardiol Sin. 2025 May;41(3):323-334. doi: 10.6515/ACS.202505_41(3).20241111D.
2
Epicardial adipose tissue in patients with and without COVID-19 infection.感染和未感染新冠病毒患者的心外膜脂肪组织
Am Heart J Plus. 2025 Apr 19;54:100548. doi: 10.1016/j.ahjo.2025.100548. eCollection 2025 Jun.
3
[Journal Club].

本文引用的文献

1
Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis.新冠病毒肺炎患者肝损伤标志物与临床结局：一项系统评价与荟萃分析
J Infect. 2021 Jan;82(1):159-198. doi: 10.1016/j.jinf.2020.05.045. Epub 2020 May 28.
2
Cardiovascular manifestations and treatment considerations in COVID-19.新型冠状病毒肺炎的心血管表现和治疗注意事项。
Heart. 2020 Aug;106(15):1132-1141. doi: 10.1136/heartjnl-2020-317056. Epub 2020 Apr 30.
3
Cardiovascular disease and COVID-19.心血管疾病与新型冠状病毒肺炎
[期刊俱乐部]
Z Gerontol Geriatr. 2024 Nov;57(7):578-580. doi: 10.1007/s00391-024-02361-w. Epub 2024 Sep 26.
4
Synergy Between NK Cells and Monocytes in Potentiating Cardiovascular Disease Risk in Severe COVID-19.NK 细胞与单核细胞的协同作用增强了重症 COVID-19 患者的心血管疾病风险。
Arterioscler Thromb Vasc Biol. 2024 Oct;44(10):e243-e261. doi: 10.1161/ATVBAHA.124.321085. Epub 2024 Jul 11.
5
Pathogen evolution, prevention/control strategy and clinical features of COVID-19: experiences from China.新型冠状病毒肺炎的病原体演变、防控策略及临床特征：来自中国的经验
Front Med. 2023 Dec;17(6):1030-1046. doi: 10.1007/s11684-023-1043-5. Epub 2023 Dec 29.
6
Cardiovascular Complications of COVID-19: A Scoping Review of Evidence.新型冠状病毒肺炎的心血管并发症：证据的范围综述
Cureus. 2023 Nov 4;15(11):e48275. doi: 10.7759/cureus.48275. eCollection 2023 Nov.
7
Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review.动脉粥样硬化、心血管疾病与2019冠状病毒病：一篇叙述性综述
Biomedicines. 2023 Apr 18;11(4):1206. doi: 10.3390/biomedicines11041206.
8
Cardiovascular Complications in Patients Hospitalized for COVID-19: A Cohort Study in Havana, Cuba.古巴哈瓦那住院 COVID-19 患者的心血管并发症：一项队列研究。
Cardiovasc Revasc Med. 2023 Jul;52:10-15. doi: 10.1016/j.carrev.2023.02.014. Epub 2023 Feb 20.
9
Association of Lung Fibrotic Changes and Cardiological Dysfunction with Comorbidities in Long COVID-19 Cohort.长新冠队列中肺纤维化改变和心功能障碍与合并症的关系。
Int J Environ Res Public Health. 2023 Jan 31;20(3):2567. doi: 10.3390/ijerph20032567.
10
Myocardial injury and its correlation to mortality in hospitalized COVID-19 patients: A retrospective cohort study.住院COVID-19患者的心肌损伤及其与死亡率的相关性：一项回顾性队列研究。
Front Cardiovasc Med. 2022 Nov 23;9:1039655. doi: 10.3389/fcvm.2022.1039655. eCollection 2022.
Diabetes Metab Syndr. 2020 May-Jun;14(3):247-250. doi: 10.1016/j.dsx.2020.03.013. Epub 2020 Mar 25.
4
2019 CORONAVIRUS: What are the implications for cardiology?2019新型冠状病毒：对心脏病学有何影响？
Eur J Prev Cardiol. 2020 May;27(8):793-796. doi: 10.1177/2047487320918102. Epub 2020 Apr 3.
5
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up.2019 年冠状病毒病在老年患者中的特征和预后因素：基于 4 周随访的研究。
J Infect. 2020 Jun;80(6):639-645. doi: 10.1016/j.jinf.2020.03.019. Epub 2020 Mar 30.
6
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).COVID-19 患者的致命结局对心血管的影响。
JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.
7
Clinical course and mortality risk of severe COVID-19.重症新型冠状病毒肺炎的临床病程及死亡风险
Lancet. 2020 Mar 28;395(10229):1014-1015. doi: 10.1016/S0140-6736(20)30633-4. Epub 2020 Mar 17.
8
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
9
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.系统评价与Meta分析优先报告条目：PRISMA声明
PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.
10
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.流行病学观察性研究的Meta分析：报告建议。流行病学观察性研究的Meta分析（MOOSE）小组。
JAMA. 2000 Apr 19;283(15):2008-12. doi: 10.1001/jama.283.15.2008.